CDK4 and oculocutaneous albinism type 1: In our case, steroid treatment was initiated on day 16 after confirming the renal biopsy results, because CDK4/6 inhibitors can cause both AIN and ATN, the latter of which has no specific treatment and is managed by supportive care.